Subclinical atrial fibrillation and the risk of stroke
- PMID: 22236222
- DOI: 10.1056/NEJMoa1105575
Subclinical atrial fibrillation and the risk of stroke
Erratum in
-
Subclinical Atrial Fibrillation and the Risk of Stroke.N Engl J Med. 2016 Mar 10;374(10):998. doi: 10.1056/NEJMx160004. N Engl J Med. 2016. PMID: 26962746 No abstract available.
Abstract
Background: One quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented atrial fibrillation. We evaluated whether subclinical episodes of rapid atrial rate detected by implanted devices were associated with an increased risk of ischemic stroke in patients who did not have other evidence of atrial fibrillation.
Methods: We enrolled 2580 patients, 65 years of age or older, with hypertension and no history of atrial fibrillation, in whom a pacemaker or defibrillator had recently been implanted. We monitored the patients for 3 months to detect subclinical atrial tachyarrhythmias (episodes of atrial rate >190 beats per minute for more than 6 minutes) and followed them for a mean of 2.5 years for the primary outcome of ischemic stroke or systemic embolism. Patients with pacemakers were randomly assigned to receive or not to receive continuous atrial overdrive pacing.
Results: By 3 months, subclinical atrial tachyarrhythmias detected by implanted devices had occurred in 261 patients (10.1%). Subclinical atrial tachyarrhythmias were associated with an increased risk of clinical atrial fibrillation (hazard ratio, 5.56; 95% confidence interval [CI], 3.78 to 8.17; P<0.001) and of ischemic stroke or systemic embolism (hazard ratio, 2.49; 95% CI, 1.28 to 4.85; P=0.007). Of 51 patients who had a primary outcome event, 11 had had subclinical atrial tachyarrhythmias detected by 3 months, and none had had clinical atrial fibrillation by 3 months. The population attributable risk of stroke or systemic embolism associated with subclinical atrial tachyarrhythmias was 13%. Subclinical atrial tachyarrhythmias remained predictive of the primary outcome after adjustment for predictors of stroke (hazard ratio, 2.50; 95% CI, 1.28 to 4.89; P=0.008). Continuous atrial overdrive pacing did not prevent atrial fibrillation.
Conclusions: Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism. (Funded by St. Jude Medical; ASSERT ClinicalTrials.gov number, NCT00256152.).
Comment in
-
How much atrial fibrillation is too much atrial fibrillation?N Engl J Med. 2012 Jan 12;366(2):178-80. doi: 10.1056/NEJMe1111948. N Engl J Med. 2012. PMID: 22236229 No abstract available.
-
Atrial fibrillation: Could subclinical AF be a missing link in the etiology of cryptogenic stroke?Nat Rev Cardiol. 2012 Jan 31;9(3):126. doi: 10.1038/nrcardio.2012.5. Nat Rev Cardiol. 2012. PMID: 22290237 No abstract available.
-
Subclinical atrial fibrillation and the risk of stroke.N Engl J Med. 2012 Apr 5;366(14):1350-1; author reply 1352-3. doi: 10.1056/NEJMc1201844. N Engl J Med. 2012. PMID: 22475606 No abstract available.
-
Subclinical atrial fibrillation and the risk of stroke.N Engl J Med. 2012 Apr 5;366(14):1351; author reply 1352-3. doi: 10.1056/NEJMc1201844. N Engl J Med. 2012. PMID: 22475607 No abstract available.
-
Subclinical atrial fibrillation and the risk of stroke.N Engl J Med. 2012 Apr 5;366(14):1351; author reply 1352-3. doi: 10.1056/NEJMc1201844. N Engl J Med. 2012. PMID: 22475608 No abstract available.
-
Subclinical atrial fibrillation and the risk of stroke.N Engl J Med. 2012 Apr 5;366(14):1351-2; author reply 1352-3. doi: 10.1056/NEJMc1201844. N Engl J Med. 2012. PMID: 22475609 No abstract available.
-
Subclinical atrial fibrillation and the risk of stroke.N Engl J Med. 2012 Apr 5;366(14):1352; author reply 1352-3. doi: 10.1056/NEJMc1201844. N Engl J Med. 2012. PMID: 22475610 No abstract available.
-
How early is early enough to prevent stroke in atrial fibrillation?Expert Rev Cardiovasc Ther. 2012 May;10(5):585-8. doi: 10.1586/erc.12.36. Expert Rev Cardiovasc Ther. 2012. PMID: 22651834
-
[Subclinical atrial fibrillation - undetected but still not benign].Praxis (Bern 1994). 2012 Jun 20;101(13):877-8. doi: 10.1024/1661-8157/a000970. Praxis (Bern 1994). 2012. PMID: 22715082 German. No abstract available.
-
Risk factors and cerebrovascular disease.J Neurol. 2013 Feb;260(2):692-4. doi: 10.1007/s00415-013-6835-0. J Neurol. 2013. PMID: 23355176 No abstract available.
Similar articles
-
Temporal relationship between subclinical atrial fibrillation and embolic events.Circulation. 2014 May 27;129(21):2094-9. doi: 10.1161/CIRCULATIONAHA.113.007825. Epub 2014 Mar 14. Circulation. 2014. PMID: 24633881 Clinical Trial.
-
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.Eur Heart J. 2017 May 1;38(17):1339-1344. doi: 10.1093/eurheartj/ehx042. Eur Heart J. 2017. PMID: 28329139
-
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12. N Engl J Med. 2024. PMID: 37952132 Clinical Trial.
-
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?Eur J Intern Med. 2024 May;123:37-41. doi: 10.1016/j.ejim.2024.01.002. Epub 2024 Jan 27. Eur J Intern Med. 2024. PMID: 38281819 Review.
-
Management of atrial fibrillation in bradyarrhythmias.Nat Rev Cardiol. 2015 Jun;12(6):337-49. doi: 10.1038/nrcardio.2015.30. Epub 2015 Mar 17. Nat Rev Cardiol. 2015. PMID: 25781413 Review.
Cited by
-
Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial.Sci Rep. 2024 Nov 12;14(1):27649. doi: 10.1038/s41598-024-74631-x. Sci Rep. 2024. PMID: 39532868 Free PMC article. Clinical Trial.
-
A prospective, multicenter, randomized controlled trial comparing VDD-ICD with VVI-ICD in detecting subclinical atrial fibrillation in patients with ICDs: The Dx-AF trial.Heart Rhythm O2. 2024 Jul 23;5(9):668-671. doi: 10.1016/j.hroo.2024.07.014. eCollection 2024 Sep. Heart Rhythm O2. 2024. PMID: 39493910 Free PMC article. No abstract available.
-
Left atrial function during exercise stress echocardiography as a sign of paroxysmal/persistent atrial fibrillation.Cardiovasc Ultrasound. 2024 Nov 4;22(1):13. doi: 10.1186/s12947-024-00332-0. Cardiovasc Ultrasound. 2024. PMID: 39491022 Free PMC article.
-
Performance of Atrial Fibrillation Burden Trends for Stroke Risk Stratification.Circ Arrhythm Electrophysiol. 2024 Nov;17(11):e012394. doi: 10.1161/CIRCEP.123.012394. Epub 2024 Oct 24. Circ Arrhythm Electrophysiol. 2024. PMID: 39445430 Free PMC article.
-
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation.Clin Kidney J. 2024 Oct 4;17(10):sfae270. doi: 10.1093/ckj/sfae270. eCollection 2024 Oct. Clin Kidney J. 2024. PMID: 39439440 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical